| NCT04318704 |
Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough |
https://ClinicalTrials.gov/show/NCT04318704 |
Recruiting |
Algernon Pharmaceuticals |
2021-03-31 |
| NCT03737409 |
PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial |
https://ClinicalTrials.gov/show/NCT03737409 |
Recruiting |
Monash University |
2023-12-01 |
| NCT03326089 |
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03326089 |
Recruiting |
Corfu General Hospital |
2020-06-01 |
| NCT03287414 |
Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03287414 |
Recruiting |
Novartis |
2022-08-31 |
| NCT03286556 |
Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03286556 |
Recruiting |
University of Alabama at Birmingham |
2021-08-01 |
| NCT03274544 |
Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT03274544 |
Recruiting |
The University of Hong Kong |
2021-06-14 |
| NCT03268915 |
Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test |
https://ClinicalTrials.gov/show/NCT03268915 |
Completed |
University Hospital, Grenoble |
2018-12-09 |
| NCT03267108 |
A Safety and Efficacy Study of Pulsed Inhaled Nitric Oxide in Pulmonary Hypertension Associated With Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03267108 |
Active, not recruiting |
Bellerophon |
2022-06-16 |
| NCT03261037 |
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period |
https://ClinicalTrials.gov/show/NCT03261037 |
Completed |
Hoffmann-La Roche |
2019-11-27 |
| NCT03222648 |
Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03222648 |
Recruiting |
University Hospital Southampton NHS Foundation Trust |
2021-12-31 |
| NCT03208933 |
Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF). |
https://ClinicalTrials.gov/show/NCT03208933 |
Completed |
Hoffmann-La Roche |
2019-11-13 |
| NCT03183570 |
Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis and Primary Sclerosing Cholangitis Using PET/CT |
https://ClinicalTrials.gov/show/NCT03183570 |
Recruiting |
Stanford University |
2021-04-14 |
| NCT03142191 |
A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03142191 |
Recruiting |
Celgene |
2021-06-30 |
| NCT03104322 |
Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03104322 |
Completed |
patientMpower Ltd. |
2018-03-09 |
| NCT03070522 |
Prednisone in Cystic Fibrosis Pulmonary Exacerbations |
https://ClinicalTrials.gov/show/NCT03070522 |
Recruiting |
The Hospital for Sick Children |
2020-05-31 |
| NCT03050255 |
Short-term Effects of Supplemental Oxygen in Patients With IPF |
https://ClinicalTrials.gov/show/NCT03050255 |
Completed |
Schön Klinik Berchtesgadener Land |
2018-03-31 |
| NCT02929017 |
Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers |
https://ClinicalTrials.gov/show/NCT02929017 |
Active, not recruiting |
University of Pittsburgh |
2020-12-31 |
| NCT02874989 |
Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial |
https://ClinicalTrials.gov/show/NCT02874989 |
Completed |
Wake Forest University Health Sciences |
2019-06-03 |
| NCT02871401 |
A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT02871401 |
Active, not recruiting |
Vanderbilt University Medical Center |
2019-12-31 |
| NCT02859194 |
The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients |
https://ClinicalTrials.gov/show/NCT02859194 |
Completed |
Yonsei University |
2016-10-14 |
| NCT02802345 |
Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment |
https://ClinicalTrials.gov/show/NCT02802345 |
Completed |
Boehringer Ingelheim |
2017-12-19 |
| NCT02788474 |
Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment |
https://ClinicalTrials.gov/show/NCT02788474 |
Completed |
Boehringer Ingelheim |
2017-08-04 |
| NCT02771184 |
Computerized Lung Sound Analysis |
https://ClinicalTrials.gov/show/NCT02771184 |
Completed |
Medical University of Graz |
2018-03-31 |
| NCT02759120 |
CleanUP IPF for the Pulmonary Trials Cooperative |
https://ClinicalTrials.gov/show/NCT02759120 |
Active, not recruiting |
Weill Medical College of Cornell University |
2020-07-31 |
| NCT02745184 |
Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02745184 |
Recruiting |
Shanghai East Hospital |
2021-04-30 |
| NCT02739165 |
Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02739165 |
Completed |
Asahi Kasei Pharma Corporation |
2018-09-30 |
| NCT02738801 |
Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 |
https://ClinicalTrials.gov/show/NCT02738801 |
Completed |
Galapagos NV |
2017-05-02 |
| NCT02713347 |
Advancing Symptom Alleviation With Palliative Treatment |
https://ClinicalTrials.gov/show/NCT02713347 |
Recruiting |
VA Office of Research and Development |
2020-12-31 |
| NCT02707640 |
A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT02707640 |
Completed |
Hoffmann-La Roche |
2015-02-28 |
| NCT02688647 |
A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02688647 |
Active, not recruiting |
Kadmon Corporation, LLC |
2020-07-31 |
| NCT02668029 |
Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02668029 |
Completed |
University of Siena |
2013-04-30 |
| NCT02648048 |
A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02648048 |
Completed |
Hoffmann-La Roche |
2016-11-30 |
| NCT02633293 |
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE |
https://ClinicalTrials.gov/show/NCT02633293 |
Active, not recruiting |
United Therapeutics |
2022-11-30 |
| NCT02630316 |
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE |
https://ClinicalTrials.gov/show/NCT02630316 |
Completed |
United Therapeutics |
2019-12-26 |
| NCT02612051 |
First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT02612051 |
Completed |
GlaxoSmithKline |
2016-06-02 |
| NCT02606877 |
A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination |
https://ClinicalTrials.gov/show/NCT02606877 |
Completed |
Boehringer Ingelheim |
2017-03-22 |
| NCT02600689 |
Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02600689 |
Completed |
University of Alabama at Birmingham |
2018-03-16 |
| NCT02598193 |
Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT02598193 |
Completed |
Hoffmann-La Roche |
2017-05-16 |
| NCT02594839 |
Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease |
https://ClinicalTrials.gov/show/NCT02594839 |
Completed |
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia |
2018-01-31 |
| NCT02594059 |
Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02594059 |
Recruiting |
Hopital Foch |
2020-05-31 |
| NCT02502097 |
A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016) |
https://ClinicalTrials.gov/show/NCT02502097 |
Completed |
Afferent Pharmaceuticals, Inc. |
2016-07-01 |
| NCT02551068 |
High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib |
https://ClinicalTrials.gov/show/NCT02551068 |
Recruiting |
University of British Columbia |
2022-04-30 |
| NCT02550873 |
A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT02550873 |
Active, not recruiting |
Promedior, Inc. |
2018-05-02 |
| NCT02538536 |
A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT02538536 |
Completed |
ProMetic BioSciences Inc. |
2017-01-31 |
| NCT02510937 |
Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02510937 |
Completed |
Celgene |
2017-02-06 |
| NCT02503657 |
Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT02503657 |
Active, not recruiting |
MediciNova |
2020-12-31 |
| NCT02477709 |
A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT02477709 |
Completed |
Afferent Pharmaceuticals, Inc. |
2015-08-07 |
| NCT02460588 |
Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02460588 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2019-01-31 |
| NCT02421120 |
Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT02421120 |
Completed |
Hartford Hospital |
2016-03-31 |
| NCT02397005 |
Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT02397005 |
Active, not recruiting |
Zai Lab Pty. Ltd. |
2016-04-30 |
| NCT02370693 |
Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02370693 |
Recruiting |
Northwestern University |
2020-06-30 |
| NCT02345070 |
Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02345070 |
Completed |
Sanofi |
2017-05-22 |
| NCT02277145 |
A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells |
https://ClinicalTrials.gov/show/NCT02277145 |
Completed |
Chinese Academy of Sciences |
2018-12-31 |
| NCT02268981 |
Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT02268981 |
Completed |
Schön Klinik Berchtesgadener Land |
2015-09-30 |
| NCT02267655 |
3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF |
https://ClinicalTrials.gov/show/NCT02267655 |
Completed |
Bellerophon |
2017-06-30 |
| NCT02257177 |
RCT (Randomized Control Trial) of TD139 vs Placebo in HV’s (Human Volunteers) and IPF Patients |
https://ClinicalTrials.gov/show/NCT02257177 |
Completed |
Galecto Biotech AB |
2016-12-31 |
| NCT03385668 |
Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies |
https://ClinicalTrials.gov/show/NCT03385668 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-09-30 |
| NCT02248064 |
Auto-titrating Oxygen in Chronic Respiratory Failure |
https://ClinicalTrials.gov/show/NCT02248064 |
Completed |
Imperial College London |
2015-11-30 |
| NCT02173145 |
Azithromycin in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02173145 |
Completed |
University Hospital Inselspital, Berne |
2019-08-16 |
| NCT02136992 |
Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02136992 |
Completed |
Shanghai Pulmonary Hospital, Shanghai, China |
2013-06-30 |
| NCT02085018 |
Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT02085018 |
Completed |
Newcastle-upon-Tyne Hospitals NHS Trust |
2016-09-27 |
| NCT02058602 |
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients |
https://ClinicalTrials.gov/show/NCT02058602 |
Completed |
GlaxoSmithKline |
2016-07-11 |
| NCT02048644 |
Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT02048644 |
Completed |
Hull University Teaching Hospitals NHS Trust |
2015-04-30 |
| NCT00001532 |
Role of Genetic Factors in the Development of Lung Disease |
https://ClinicalTrials.gov/show/NCT00001532 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2025-08-01 |
| NCT02036970 |
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT |
https://ClinicalTrials.gov/show/NCT02036970 |
Completed |
Reata Pharmaceuticals, Inc. |
2018-01-19 |
| NCT02036580 |
D2212C00002 J-Phase II Study |
https://ClinicalTrials.gov/show/NCT02036580 |
Completed |
AstraZeneca |
2015-11-30 |
| NCT02019641 |
The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease |
https://ClinicalTrials.gov/show/NCT02019641 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-12-31 |
| NCT02013700 |
Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER) |
https://ClinicalTrials.gov/show/NCT02013700 |
Completed |
University of Miami |
2015-12-11 |
| NCT01979952 |
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT01979952 |
Completed |
Boehringer Ingelheim |
2016-10-27 |
| NCT01969409 |
Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01969409 |
Active, not recruiting |
University of Alabama at Birmingham |
2019-01-31 |
| NCT01919827 |
Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01919827 |
Completed |
Clinica Universidad de Navarra, Universidad de Navarra |
2018-05-01 |
| NCT01916577 |
Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation |
https://ClinicalTrials.gov/show/NCT01916577 |
Completed |
University of Colorado, Denver |
2017-10-31 |
| NCT01890265 |
Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01890265 |
Completed |
FibroGen |
2017-07-28 |
| NCT01872689 |
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT01872689 |
Completed |
Hoffmann-La Roche |
2017-07-28 |
| NCT01817686 |
Study of Default Options in Advance Directives |
https://ClinicalTrials.gov/show/NCT01817686 |
Completed |
Corporal Michael J. Crescenz VA Medical Center |
2015-06-30 |
| NCT01772667 |
Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01772667 |
Completed |
Schön Klinik Berchtesgadener Land |
2016-06-30 |
| NCT01766817 |
Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01766817 |
Completed |
Bristol-Myers Squibb |
2016-02-29 |
| NCT01725139 |
A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT01725139 |
Completed |
GlaxoSmithKline |
2016-07-12 |
| NCT01653730 |
Comparative Study of 3 Portable Oxygen Concentrators During a 6-minute Walk Test in Patients With Chronic Lung Disease |
https://ClinicalTrials.gov/show/NCT01653730 |
Completed |
Ottawa Hospital Research Institute |
2010-08-31 |
| NCT01637831 |
CPAP Therapy in Patients With Idiopathic Pulmonary Fibrosis and Sleep Apnea |
https://ClinicalTrials.gov/show/NCT01637831 |
Completed |
University of Crete |
2011-09-30 |
| NCT01619085 |
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01619085 |
Active, not recruiting |
Boehringer Ingelheim |
2017-07-05 |
| NCT01615484 |
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability |
https://ClinicalTrials.gov/show/NCT01615484 |
Completed |
University of North Carolina, Chapel Hill |
2016-03-31 |
| NCT01529853 |
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT01529853 |
Completed |
Sanofi |
2013-10-31 |
| NCT03890250 |
Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03890250 |
Recruiting |
Biruni University |
2020-03-01 |
| NCT01462006 |
Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT01462006 |
Active, not recruiting |
University of Virginia |
2018-11-30 |
| NCT01457261 |
IPF Drug Deposition Study |
https://ClinicalTrials.gov/show/NCT01457261 |
Completed |
Royal Brompton & Harefield NHS Foundation Trust |
2014-11-30 |
| NCT01442779 |
Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01442779 |
Completed |
Texas Tech University Health Sciences Center |
2007-05-31 |
| NCT01417156 |
Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174) |
https://ClinicalTrials.gov/show/NCT01417156 |
Completed |
Boehringer Ingelheim |
2015-10-31 |
| NCT01385644 |
A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01385644 |
Completed |
The Prince Charles Hospital |
2013-05-31 |
| NCT01371305 |
STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT01371305 |
Completed |
Biogen |
2017-03-31 |
| NCT01366209 |
Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT01366209 |
Completed |
Genentech, Inc. |
2014-02-28 |
| NCT01362231 |
A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01362231 |
Completed |
Gilead Sciences |
2012-12-31 |
| NCT01335477 |
Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II |
https://ClinicalTrials.gov/show/NCT01335477 |
Completed |
Boehringer Ingelheim |
2013-10-31 |
| NCT01335464 |
Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT01335464 |
Completed |
Boehringer Ingelheim |
2013-10-31 |
| NCT04396756 |
Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT04396756 |
Recruiting |
Pliant Therapeutics, Inc. |
2021-12-31 |
| NCT04326036 |
Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04326036 |
Enrolling by invitation |
Healeon Medical Inc |
2021-11-01 |
| NCT04279197 |
Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu |
https://ClinicalTrials.gov/show/NCT04279197 |
Recruiting |
ShuGuang Hospital |
2022-12-31 |
| NCT04233814 |
Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT04233814 |
Recruiting |
Lung Therapeutics, Inc |
2020-11-01 |
| NCT04197791 |
Effect of Core Stabilization Exercises and Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT04197791 |
Active, not recruiting |
Istanbul University-Cerrahpasa |
2020-11-30 |
| NCT04196179 |
ANG-3070 in Healthy Adult Participants |
https://ClinicalTrials.gov/show/NCT04196179 |
Recruiting |
Angion Biomedica Corp |
2020-08-31 |
| NCT04072315 |
Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/ |
https://ClinicalTrials.gov/show/NCT04072315 |
Recruiting |
Pliant Therapeutics, Inc. |
2020-10-31 |
| NCT04069143 |
Safety, Tolerability, Kinetics, and Repeatability of the Novel LPA1 PET Ligand 18F-BMS-986327 |
https://ClinicalTrials.gov/show/NCT04069143 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-07-16 |
| NCT04030026 |
A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough |
https://ClinicalTrials.gov/show/NCT04030026 |
Active, not recruiting |
Trevi Therapeutics |
2021-03-31 |
| NCT03981406 |
Palliative Care and Quality of Life in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03981406 |
Completed |
University of Minnesota |
2019-03-01 |
| NCT03981094 |
A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants |
https://ClinicalTrials.gov/show/NCT03981094 |
Completed |
Bristol-Myers Squibb |
2019-07-27 |
| NCT03979703 |
Yoga in Patients With Fibrosing Interstitial Lung Diseases |
https://ClinicalTrials.gov/show/NCT03979703 |
Recruiting |
Heidelberg University |
2019-12-31 |
| NCT03979430 |
Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot Study |
https://ClinicalTrials.gov/show/NCT03979430 |
Recruiting |
Heidelberg University |
2020-07-30 |
| NCT03955146 |
Evaluation of Efficacy and Safety of Pamrevlumab in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03955146 |
Recruiting |
FibroGen |
2022-12-31 |
| NCT03949530 |
A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03949530 |
Recruiting |
Indalo Therapeutics, Inc. |
2020-06-30 |
| NCT03928847 |
Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis. |
https://ClinicalTrials.gov/show/NCT03928847 |
Recruiting |
University of California, San Francisco |
2020-12-31 |
| NCT03832946 |
A Study to Test the Efficacy and Safety of Inhaled TD139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT03832946 |
Recruiting |
Galecto Biotech AB |
2021-12-31 |
| NCT03830125 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT03830125 |
Completed |
Bridge Biotherapeutics, Inc. |
2019-11-24 |
| NCT03752892 |
Partitioned Training of Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03752892 |
Recruiting |
West Park Healthcare Centre |
2021-03-31 |
| NCT03727802 |
Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03727802 |
Recruiting |
Toray Industries, Inc |
2020-12-31 |
| NCT03727451 |
A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis |
https://ClinicalTrials.gov/show/NCT03727451 |
Recruiting |
Bellerophon |
2020-06-30 |
| NCT03725852 |
A Clinical Study to Test How Effective and Safe GLPG1205 is for Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT03725852 |
Active, not recruiting |
Galapagos NV |
2020-07-31 |
| NCT03717012 |
Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT03717012 |
Recruiting |
Boehringer Ingelheim |
2020-06-15 |
| NCT03711162 |
A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care |
https://ClinicalTrials.gov/show/NCT03711162 |
Recruiting |
Galapagos NV |
2021-12-31 |
| NCT03692481 |
Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving Pirfenidone |
https://ClinicalTrials.gov/show/NCT03692481 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-05-15 |
| NCT03688334 |
Acute Effects of Oxygen Supplementation Among IPF Patients |
https://ClinicalTrials.gov/show/NCT03688334 |
Recruiting |
George Papanicolaou Hospital |
2019-06-01 |
| NCT03650075 |
To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03650075 |
Recruiting |
Metagone Biotech Inc. |
2021-12-31 |
| NCT03619616 |
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03619616 |
Completed |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. |
2019-06-28 |
| NCT03584802 |
Therapeutic Plasma Exchange, Rituximab and IV Ig for Severe Acute Exacerbation of IPF Admitted in ICU |
https://ClinicalTrials.gov/show/NCT03584802 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-10-01 |
| NCT03562416 |
Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects |
https://ClinicalTrials.gov/show/NCT03562416 |
Recruiting |
Temple University |
2021-12-31 |
| NCT03562247 |
Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT03562247 |
Recruiting |
Vanderbilt University Medical Center |
2023-08-31 |
| NCT03560154 |
Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease |
https://ClinicalTrials.gov/show/NCT03560154 |
Active, not recruiting |
Istanbul University |
2019-09-30 |
| NCT03538301 |
JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF |
https://ClinicalTrials.gov/show/NCT03538301 |
Recruiting |
Nitto Denko Corporation |
2021-07-31 |
| NCT03535545 |
Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients |
https://ClinicalTrials.gov/show/NCT03535545 |
Recruiting |
Massachusetts General Hospital |
2021-03-31 |
| NCT03508375 |
Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis |
https://ClinicalTrials.gov/show/NCT03508375 |
Recruiting |
Assistance Publique Hopitaux De Marseille |
2021-05-31 |
| NCT03500731 |
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure |
https://ClinicalTrials.gov/show/NCT03500731 |
Recruiting |
University of Pittsburgh |
2023-12-31 |
| NCT03499275 |
Muscle Stimulation in Advanced Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03499275 |
Active, not recruiting |
Royal Brompton & Harefield NHS Foundation Trust |
2020-03-31 |
| NCT03477526 |
Status and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary Rehabilitation |
https://ClinicalTrials.gov/show/NCT03477526 |
Recruiting |
Schön Klinik Berchtesgadener Land |
2021-02-28 |
| NCT03455686 |
Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease |
https://ClinicalTrials.gov/show/NCT03455686 |
Recruiting |
McMaster University |
2023-03-31 |
| NCT03422068 |
This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated. |
https://ClinicalTrials.gov/show/NCT03422068 |
Completed |
Boehringer Ingelheim |
2019-07-01 |
| NCT03420235 |
Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life |
https://ClinicalTrials.gov/show/NCT03420235 |
Completed |
Erasmus Medical Center |
2019-08-26 |
| NCT03411876 |
Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT03411876 |
Completed |
Schön Klinik Berchtesgadener Land |
2019-01-15 |
| NCT01266317 |
Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations |
https://ClinicalTrials.gov/show/NCT01266317 |
Completed |
University of Pittsburgh |
2015-07-31 |
| NCT01265888 |
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. |
https://ClinicalTrials.gov/show/NCT01265888 |
Completed |
Geno LLC |
2016-09-30 |
| NCT01262001 |
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01262001 |
Completed |
FibroGen |
2014-06-26 |
| NCT01254409 |
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT01254409 |
Completed |
Promedior, Inc. |
2012-07-31 |
| NCT01214187 |
Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01214187 |
Completed |
Brigham and Women’s Hospital |
2014-10-31 |
| NCT01199887 |
Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT01199887 |
Completed |
ImmuneWorks |
2012-10-31 |
| NCT01170065 |
Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT01170065 |
Completed |
Boehringer Ingelheim |
2016-09-26 |
| NCT01136174 |
Safety and PK Study of BIBF 1120 in Japanese Patients With IPF |
https://ClinicalTrials.gov/show/NCT01136174 |
Completed |
Boehringer Ingelheim |
2011-03-31 |
| NCT01118221 |
Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients |
https://ClinicalTrials.gov/show/NCT01118221 |
Completed |
VA Office of Research and Development |
2013-09-30 |
| NCT00934362 |
Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease |
https://ClinicalTrials.gov/show/NCT00934362 |
Completed |
University of North Carolina, Chapel Hill |
2010-08-31 |
| NCT00911794 |
Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease |
https://ClinicalTrials.gov/show/NCT00911794 |
Completed |
Winthrop University Hospital |
2008-01-31 |
| NCT00903331 |
Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study |
https://ClinicalTrials.gov/show/NCT00903331 |
Completed |
Actelion |
2011-06-30 |
| NCT03503188 |
Digital Auscultation Test - IPF Data Collection |
https://ClinicalTrials.gov/show/NCT03503188 |
Completed |
Boehringer Ingelheim |
2019-01-03 |
| NCT03229343 |
Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis. |
https://ClinicalTrials.gov/show/NCT03229343 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-02-29 |
| NCT02951429 |
Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT02951429 |
Active, not recruiting |
Hoffmann-La Roche |
2019-09-26 |
| NCT02846324 |
Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF |
https://ClinicalTrials.gov/show/NCT02846324 |
Completed |
Global Blood Therapeutics |
2017-09-30 |
| NCT02579603 |
Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF |
https://ClinicalTrials.gov/show/NCT02579603 |
Completed |
Boehringer Ingelheim |
2017-01-03 |
| NCT03207997 |
MRI Quantification of Pulmonary Fibrosis in Scleroderma Patients |
https://ClinicalTrials.gov/show/NCT03207997 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2018-03-09 |
| NCT04138173 |
Enhancing Physical Activity in Patients With Interstitial Lung Disease |
https://ClinicalTrials.gov/show/NCT04138173 |
Recruiting |
KU Leuven |
2021-10-31 |
| NCT03733444 |
A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care |
https://ClinicalTrials.gov/show/NCT03733444 |
Recruiting |
Galapagos NV |
2021-12-31 |
| NCT00879879 |
Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00879879 |
Completed |
University of South Florida |
2012-03-31 |
| NCT00786201 |
A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT00786201 |
Completed |
Centocor, Inc. |
2012-01-31 |
| NCT00705133 |
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension |
https://ClinicalTrials.gov/show/NCT00705133 |
Completed |
University of California, Los Angeles |
2011-01-31 |
| NCT00692796 |
Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00692796 |
Completed |
National Jewish Health |
2010-03-31 |
| NCT00662038 |
Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT00662038 |
Completed |
Genentech, Inc. |
2016-02-29 |
| NCT00650091 |
Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF |
https://ClinicalTrials.gov/show/NCT00650091 |
Completed |
Duke University |
2013-10-31 |
| NCT00639496 |
Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT00639496 |
Completed |
Zambon SpA |
2003-07-31 |
| NCT00631475 |
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443 |
https://ClinicalTrials.gov/show/NCT00631475 |
Completed |
Actelion |
2010-04-30 |
| NCT00600028 |
Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide |
https://ClinicalTrials.gov/show/NCT00600028 |
Completed |
Johns Hopkins University |
2011-09-30 |
| NCT00563212 |
A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00563212 |
Completed |
NYU Langone Health |
2010-06-01 |
| NCT00532233 |
SD, IL-13 Production Rate in IPF |
https://ClinicalTrials.gov/show/NCT00532233 |
Completed |
Novartis |
2009-06-30 |
| NCT00517933 |
Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00517933 |
Completed |
Duke University |
2009-05-31 |
| NCT00514683 |
Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00514683 |
Completed |
Boehringer Ingelheim |
2010-06-30 |
| NCT00463983 |
Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide |
https://ClinicalTrials.gov/show/NCT00463983 |
Completed |
Institut National de la Santé Et de la Recherche Médicale, France |
2010-01-31 |
| NCT00455767 |
Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients |
https://ClinicalTrials.gov/show/NCT00455767 |
Completed |
Debiopharm International SA |
2007-09-30 |
| NCT00391443 |
BUILD 3: Bosentan Use in Interstitial Lung Disease |
https://ClinicalTrials.gov/show/NCT00391443 |
Completed |
Actelion |
2010-02-28 |
| NCT00359736 |
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00359736 |
Completed |
VA Office of Research and Development |
2008-10-31 |
| NCT00357279 |
Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease |
https://ClinicalTrials.gov/show/NCT00357279 |
Completed |
Merck Sharp & Dohme Corp. |
2008-09-30 |
| NCT00352482 |
Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension |
https://ClinicalTrials.gov/show/NCT00352482 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00287729 |
Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00287729 |
Completed |
Genentech, Inc. |
2008-11-30 |
| NCT00287716 |
Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00287716 |
Completed |
Genentech, Inc. |
2008-11-10 |
| NCT00262405 |
Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00262405 |
Completed |
University of Michigan |
2007-05-31 |
| NCT00189176 |
Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00189176 |
Completed |
University of Michigan |
2006-05-31 |
| NCT00162760 |
Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide |
https://ClinicalTrials.gov/show/NCT00162760 |
Completed |
Johns Hopkins University |
NA |
| NCT00131274 |
Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study |
https://ClinicalTrials.gov/show/NCT00131274 |
Completed |
Daniels, Craig E., M.D. |
NA |
| NCT00130182 |
A Study in Pediatric Patients With Cystic Fibrosis Lung Disease |
https://ClinicalTrials.gov/show/NCT00130182 |
Completed |
Merck Sharp & Dohme Corp. |
2006-09-30 |
| NCT00125385 |
Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT00125385 |
Completed |
Sanofi |
2008-09-30 |
| NCT00109681 |
Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00109681 |
Completed |
Actelion |
2006-10-31 |
| NCT00105183 |
EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection |
https://ClinicalTrials.gov/show/NCT00105183 |
Completed |
Neovii Biotech |
2010-01-31 |
| NCT00103714 |
Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease |
https://ClinicalTrials.gov/show/NCT00103714 |
Completed |
Merck Sharp & Dohme Corp. |
2005-08-31 |
| NCT00080223 |
Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00080223 |
Completed |
Genentech, Inc. |
2015-04-30 |
| NCT00074698 |
Safety and Tolerability Study of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00074698 |
Completed |
FibroGen |
NA |
| NCT00071461 |
Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00071461 |
Completed |
Actelion |
2005-09-30 |
| NCT00070590 |
Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma |
https://ClinicalTrials.gov/show/NCT00070590 |
Completed |
Actelion |
2005-09-30 |
| NCT00063869 |
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT00063869 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-03-31 |
| NCT00056147 |
Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease |
https://ClinicalTrials.gov/show/NCT00056147 |
Completed |
Merck Sharp & Dohme Corp. |
2004-02-29 |
| NCT00052052 |
An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT00052052 |
Completed |
InterMune |
NA |
| NCT00047658 |
A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT00047658 |
Completed |
InterMune |
NA |
| NCT00047645 |
A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
https://ClinicalTrials.gov/show/NCT00047645 |
Completed |
InterMune |
NA |
| NCT00004563 |
Scleroderma Lung Disease |
https://ClinicalTrials.gov/show/NCT00004563 |
Completed |
The University of Texas Health Science Center, Houston |
2013-05-31 |
| NCT00001596 |
Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome |
https://ClinicalTrials.gov/show/NCT00001596 |
Completed |
National Institutes of Health Clinical Center (CC) |
2009-09-30 |
| NCT00000596 |
Diffuse Fibrotic Lung Disease |
https://ClinicalTrials.gov/show/NCT00000596 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |